Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC4338 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Prostate Cancer |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human Prostate Cancer Peripheral Blood Mononuclear Cells are immune cells isolated from the peripheral blood of prostate cancer patients, primarily comprising lymphocytes (T cells, B cells, NK cells) and monocytes. These cells play critical roles in antitumor immune responses, including antigen presentation (monocytes/macrophages), cytotoxic activity (NK cells/CD8+ T cells), and antibody production (B cells). In prostate cancer, PBMCs often exhibit altered immune function, such as expansion of immunosuppressive regulatory T cell (Treg) or impaired cytotoxic T cell responses, which contribute to tumor immune evasion.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human Prostate Cancer Peripheral Blood Mononuclear Cells can be used to study immune cell dysfunction, such as T-cell exhaustion or regulatory T-cell (Treg) expansion, which contribute to immune evasion in prostate cancer. They can also serve as a platform for developing immunotherapies, including immune checkpoint inhibitor studies, adoptive cell therapies (e.g., CAR-T cells), and cancer vaccine development.